AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Bio Essence Corporation

$0.18 +$0.12 (+203.33%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.18
Day Range
$0.18$0.18
Year Range
$0.05$0.52
Market Cap
7.21M
AVG Volume
860
Trailing/Forward PE
4.88/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
-1M01M2M3M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q22.91M
26 Q12.38M
25 Q41.9M
25 Q3565.67K
25 Q2563.56K
25 Q1346.13K
24 Q4323.94K
24 Q3-28.71K
24 Q2-7.7K
24 Q1210.18K
Net Income (USD) · TTM
-2M-1M01M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q21.52M
26 Q11.31M
25 Q4896.2K
25 Q3-160.45K
25 Q2-1.37M
25 Q1-1.65M
24 Q4-1.6M
24 Q3-1.76M
24 Q2-878.21K
24 Q1-947.04K
Operating Income (USD) · TTM
-1M01M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q21.54M
26 Q11.32M
25 Q4900.01K
25 Q3-125.76K
25 Q2-286.46K
25 Q1-512.7K
24 Q4-369.63K
24 Q3-564.33K
24 Q2-765.03K
24 Q1-826.76K
EBITDA (USD) · TTM
-2M-1M01M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q21.64M
26 Q11.32M
25 Q4900.01K
25 Q3-156.94K
25 Q2-1.37M
25 Q1-1.64M
24 Q4-1.56M
24 Q3-1.74M
24 Q2-735.14K
24 Q1-793.08K
Cash Flows (USD) · TTM
-1M01M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q21.08M
26 Q11.18M
25 Q41.57M
25 Q3751.77K
25 Q2921.93K
25 Q1769.41K
24 Q4623.87K
24 Q3-3.29K
24 Q2-708.89K
24 Q1-969.17K
EPS (USD) · TTM
-0.05-0.0300.030.0524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q20.04
26 Q10.03
25 Q40.02
25 Q3-0
25 Q2-0.04
25 Q1-0.04
24 Q4-0.04
24 Q3-0.05
24 Q2-0.02
24 Q1-0.03
Expenses (USD) · TTM
-250K0250K500K750K1MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2489.83K
26 Q1406.28K
25 Q4528.4K
25 Q3517.65K
25 Q2663.58K
25 Q1750.36K
24 Q4676.51K
24 Q3595.45K
24 Q2739.02K
24 Q1881.23K
Shares Outstanding (USD) · TTM
00.250.50.751Buybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BIOE Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
Employee Count
051015202020212022202320242025
BIOE Employee Count by quarter
PeriodEmployee Count
20254
20242
202312
202211
202115
202011
PE Ratio
510152025med 9.28Apr 26May 26May 26Jun 26Jul 26Aug 26Sep 26
BIOE PE Ratio by quarter
PeriodPE Ratio
Sep 266.1
Sep 266.1
Sep 266.37
Aug 266.37
Aug 268.38
Aug 268.38
Aug 268.6
Jul 269.28
Jul 269.28
Jul 269.28
Jul 269.28
Jul 269.28
Jun 269.28
Jun 266.25
Jun 268.7
Jun 268.68
May 269.42
May 269.42
May 2613.07
May 2621.21
May 2621.21
Apr 2619.09
Apr 2616.96
Apr 2616.96
Apr 267.83
Mar 267.21
Free Cash Flow Yield
-20%0%20%40%60%med 10.42%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2611.62%
Sep 2611.62%
Sep 2611.13%
Aug 2611.13%
Aug 268.46%
Aug 268.46%
Aug 2610.53%
Jul 269.75%
Jul 269.75%
Jul 269.75%
Jul 269.75%
Jul 269.75%
Jun 269.75%
Jun 2614.48%
Jun 2610.41%
Jun 2610.43%
May 269.61%
May 269.61%
May 266.93%
May 268.26%
May 268.26%
Apr 269.18%
Apr 2610.32%
Apr 2610.32%
Apr 2622.37%
Mar 2624.29%
Mar 2613.19%
Mar 2635.96%
Mar 2635.96%
Feb 2621.98%
Feb 2638.78%
Feb 2635.96%
Feb 2635.96%
Jan 2638.78%
Jan 2638.78%
Jan 2638.78%
Jan 2634.1%
Jan 2632.96%
Dec 2535.96%
Dec 2532.42%
Dec 2538.04%
Dec 2538.04%
Nov 2538.04%
Nov 2538.04%
Nov 2534.1%
Nov 2541.82%
Oct 2534.16%
Oct 2535.15%
Oct 2535.31%
Oct 2528.2%
Oct 2526.65%
Sep 2526.36%
Sep 2526.36%
Sep 2525.8%
Sep 2526.65%
Aug 2520.21%
Aug 2520.21%
Aug 2525.53%
Aug 2521.31%
Aug 2517.99%
Jul 2518.4%
Jul 2514.75%
Jul 2521.31%
Jul 2521.31%
Jun 2518.4%
Jun 2518.4%
Jun 2511.91%
Jun 258.8%
May 258.8%
May 259.55%
May 259.55%
May 257.74%
May 257.14%
Apr 257.97%
Apr 257.97%
Apr 257.67%
Apr 256.57%
Mar 256.59%
Mar 25-0.04%
Mar 25-0.04%
Mar 25-0.04%
Feb 25-0.03%
Feb 25-0.03%
Feb 25-0.03%
Feb 25-0.03%
Jan 25-0.03%
Jan 25-0.03%
Jan 25-0.03%
Jan 25-0.04%
Jan 25-0.04%
Dec 24-0.03%
Dec 24-0.03%
Dec 24-0.03%
Dec 24-0.03%
Nov 24-0.04%
Nov 24-0.03%
Nov 24-0.03%
Nov 24-6.78%
Nov 24-4.91%
Oct 24-3.36%
Price to Sales
-2000-100001000med 4.69Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOE Price to Sales by quarter
PeriodPrice to Sales
Sep 263.18
Sep 263.18
Sep 263.32
Aug 263.32
Aug 264.37
Aug 264.37
Aug 264.73
Jul 265.11
Jul 265.11
Jul 265.11
Jul 265.11
Jul 265.11
Jun 265.11
Jun 263.44
Jun 264.79
Jun 264.78
May 265.18
May 265.18
May 267.19
May 2610.02
May 2610.02
Apr 269.01
Apr 268.01
Apr 268.01
Apr 263.7
Mar 263.41
Mar 2610.08
Mar 263.7
Mar 263.7
Feb 266.05
Feb 263.43
Feb 263.7
Feb 263.7
Jan 263.43
Jan 263.43
Jan 263.43
Jan 263.9
Jan 264.03
Dec 253.7
Dec 254.1
Dec 253.49
Dec 253.49
Nov 253.49
Nov 253.49
Nov 253.9
Nov 253.91
Oct 254.79
Oct 254.65
Oct 254.63
Oct 255.8
Oct 256.14
Sep 256.2
Sep 256.2
Sep 256.34
Sep 256.14
Aug 258.09
Aug 258.09
Aug 256.41
Aug 2510.43
Aug 2512.35
Jul 2512.08
Jul 2515.07
Jul 2510.43
Jul 2510.43
Jun 2512.08
Jun 2512.08
Jun 2518.67
Jun 2525.26
May 2525.26
May 2523.28
May 2523.28
May 2524.87
May 2526.99
Apr 2524.17
Apr 2524.17
Apr 2525.11
Apr 2529.33
Mar 2529.22
Mar 25-272.75
Mar 25-267.45
Mar 25-284.67
Feb 25-337.89
Feb 25-450.17
Feb 25-450.17
Feb 25-428.66
Jan 25-397.21
Jan 25-450.17
Jan 25-336.3
Jan 25-293.94
Jan 25-284.67
Dec 24-357.49
Dec 24-425.01
Dec 24-397.08
Dec 24-331.01
Nov 24-317.77
Nov 24-344.25
Nov 24-333.54
Nov 24-1357.36
Nov 24-1875.28
Oct 24137.44
EV/EBITDA
510152025med 10.35Apr 26May 26May 26Jun 26Jul 26Aug 26Sep 26
BIOE EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 266.59
Sep 266.59
Sep 266.84
Aug 266.84
Aug 268.7
Aug 268.7
Aug 269.67
Jul 2610.35
Jul 2610.35
Jul 2610.35
Jul 2610.35
Jul 2610.35
Jun 2610.35
Jun 267.35
Jun 269.77
Jun 269.75
May 2610.48
May 2610.48
May 2614.09
May 2622.85
May 2622.85
Apr 2620.74
Apr 2618.63
Apr 2618.63
Apr 269.53
Mar 268.92
Price/Operating Cashflow
05101520med 5.5May 25Jul 25Oct 25Jan 26Apr 26Jun 26Sep 26
BIOE Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 268.61
Sep 268.61
Sep 268.99
Aug 268.99
Aug 2611.83
Aug 2611.83
Aug 269.49
Jul 2610.25
Jul 2610.25
Jul 2610.25
Jul 2610.25
Jul 2610.25
Jun 2610.25
Jun 266.91
Jun 269.61
Jun 269.59
May 2610.4
May 2610.4
May 2614.43
May 2612.11
May 2612.11
Apr 2610.9
Apr 269.69
Apr 269.69
Apr 264.47
Mar 264.12
Mar 267.58
Mar 262.78
Mar 262.78
Feb 264.55
Feb 262.58
Feb 262.78
Feb 262.78
Jan 262.58
Jan 262.58
Jan 262.58
Jan 262.93
Jan 263.03
Dec 252.78
Dec 253.08
Dec 252.63
Dec 252.63
Nov 252.63
Nov 252.63
Nov 252.93
Nov 252.39
Oct 252.93
Oct 252.84
Oct 252.83
Oct 253.55
Oct 253.75
Sep 253.79
Sep 253.79
Sep 253.88
Sep 253.75
Aug 254.95
Aug 254.95
Aug 253.92
Aug 254.69
Aug 255.56
Jul 255.43
Jul 256.78
Jul 254.69
Jul 254.69
Jun 255.43
Jun 255.43
Jun 258.4
Jun 2511.36
May 2511.36
May 2510.47
May 2510.47
May 2512.92
May 2514.01
Apr 2512.55
Apr 2512.55
Apr 2513.04
Apr 2515.23
Mar 2515.17
Price to Book
3.544.555.5med 4.13Aug 26Aug 26Aug 26Sep 26Sep 26Sep 26
BIOE Price to Book by quarter
PeriodPrice to Book
Sep 263.95
Sep 263.95
Sep 264.13
Aug 264.13
Aug 265.43
Aug 265.43
Bio Essence Corporation
BIOE
Stockpicker

Video analysis: BIOE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.